GLYCOMIRA

glycomira-logo

GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.

#SimilarOrganizations #People #Website #More

GLYCOMIRA

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2008-01-01

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.glycomira.com

Total Employee:
1+

Status:
Active

Contact:
1-801-649-3999

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Google Apps For Business Google Maps GoDaddy DNS WordPress 6.0


Similar Organizations

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

Current Employees Featured

glenn-prestwich_image

Glenn Prestwich
Glenn Prestwich Chief Scientific Officer @ GlycoMira
Chief Scientific Officer
2008-04-01

william-p-tew_image

William P. Tew
William P. Tew CEO @ GlycoMira
CEO

Official Site Inspections

http://www.glycomira.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.107
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "GlycoMira"

About Us | GlycoMira.com

GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. GlycoMiraโ€™s dedicated โ€ฆSee details»

GlycoMira - Crunchbase Company Profile & Funding

Organization. GlycoMira . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. GlycoMira develops โ€ฆSee details»

Investors | GlycoMira.com

1 As of 2024, the criteria for an individual to be considered an accredited investor include: Income Requirement: An individual must have an annual income exceeding $200,000 (or $300,000 โ€ฆSee details»

GlycoMira Company Profile - Office Locations, Competitors ... - Craft

GlycoMira is a biotechnology company developing drug candidates against inflammatory diseases. It offers synthetic glycosaminoglycan-based therapeutics that modulate innate โ€ฆSee details»

GLYCOMIRA THERAPEUTICS, INC. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for GLYCOMIRA THERAPEUTICS, INC. of Salt Lake City, UT. Get the latest business insights from Dun & โ€ฆSee details»

GlycoMira - Products, Competitors, Financials, Employees, โ€ฆ

GlycoMira Therapeutics Secures Groundbreaking Patent for Novel Cancer Treatment. Nov 4, 2024. Salt Lake City, UT, November 04, 2024 โ€” GlycoMira Therapeutics announced that the โ€ฆSee details»

GlycoMira - The Org

GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases. Industries. Biotechnology, Health Care + 2See details»

GlycoMira - Contacts, Employees, Board Members, Advisors

GlycoMira develops synthetic glycosaminoglycan-based therapeutics for mucosal diseases.See details»

GLYCOMIRA, LLC Company Profile | Dover, DE - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for GLYCOMIRA, LLC of Dover, DE. Get the latest business insights from Dun & Bradstreet.See details»

GlycoMira Therapeuticsโ€™ First-in-Class, Immune-Modulating โ€ฆ

Dr. Tew: GlycoMira Therapeutics is a Salt Lake City-based biopharmaceutical firm founded over a decade ago for technology exclusively licensed from the University of Utah. I joined the โ€ฆSee details»

GlycoMira Press Release 20211026 | GlycoMira.com

Oct 26, 2021 GlycoMira Therapeutics is a privately owned Salt Lake City based biopharmaceutical company focused on the pre-clinical development of innovative anti โ€ฆSee details»

GLYCOMIRA, LLC - VentureRadar

GlycoMira is developing an effective treatment for chronic rhinosinusitis, a debilitating inflammatory disease that substantially diminishes the quality of life and productivity of up to โ€ฆSee details»

GlycoMira Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore GlycoMira Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature, Disease Domain:Neoplasms, Technology Platform:Small molecule โ€ฆSee details»

Award - SBIR

Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means โ€ฆSee details»

GLYCOMIRA, LLC - VentureRadar

GlycoMira is developing an effective treatment for chronic rhinosinusitis, a debilitating inflammatory disease that substantially diminishes the quality of life and productivity of up to โ€ฆSee details»

GLYCOMIRA, LLC Company Profile | Salt Lake City, UT

Find company research, competitor information, contact details & financial data for GLYCOMIRA, LLC of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»

Award - SBIR

GlycoMira has developed a family of polyanionic, metabolically stabilized polysaccharides, the semi- synthetic glycosaminoglycan ethers (SAGEs). These new drugs have broad anti โ€ฆSee details»

GLYCOMIRA, LLC | SBIR.gov

PROJECT SUMMARYThe goal of this proposal is to optimize and clinically validate a new diagnostic test for eosinophilic chronic rhinosinusitis (eCRS) at the point-of-care, improving the โ€ฆSee details»

Technology | GlycoMira.com

Most therapeutic strategies for oncology target key molecules involved in the late stages of disease progression and are not mechanistically based on the recent understanding of โ€ฆSee details»

GlycoMira - Tech Stack, Apps, Patents & Trademarks - Crunchbase

GlycoMira uses 7 technology products and services including HTML5, Google Fonts, and GoDaddy Premium DNS, according to G2 Stack. GlycoMira is actively using 23 technologies โ€ฆSee details»

linkstock.net © 2022. All rights reserved